Melatonin not working? Why it fails and who it helps
Reviewed 21 sourcesPublished by PepVault
Melatonin not working? Who responds in trials, why it fails for most insomnia, and the checks in order: timing, light, caffeine, smoking and medicines.

- Last reviewed
- Sources
- 21
- Questions
- 8
- Compounds
- 1
The short answer
Usually because your problem is not one melatonin fixes, or something is cancelling it. It is a clock signal, not a sedative: pooled across trials it gets people to sleep about 7 minutes sooner, while night owls with a measured late clock fell asleep 34 minutes earlier. Check the hour, evening light, caffeine, smoking and your medicines; for chronic insomnia, CBT-I comes first.
Evidence: Randomised trials and meta-analyses for who responds; small pharmacology studies in volunteers for the interactions; a three-patient case series for loss of response.

Why does melatonin work for some people and not others?
Because it fixes one kind of sleep problem far better than the other. Melatonin is the hormone the brain releases after dark to tell the body clock that night has started; it is a timing signal, not a sedative. Where the clock runs late, or the body's own melatonin has been turned down, a pill has something to correct. Where the clock keeps good time and the trouble is a busy mind, it has much less to work on.
| Who was treated | Study | What melatonin did against placebo (a dummy pill) |
|---|---|---|
| Adults and children with primary sleep disorders | 19 trials, 1,683 people1 | Asleep 7 minutes sooner, 8 minutes more sleep |
| Adults with chronic insomnia and no other illness | 24 trials pooled, adults analysed apart2 | No significant gain in time to fall asleep, total sleep or sleep efficiency |
| Insomnia, aged 55 and over, 2 mg prolonged-release | Two 3-week trials3 | 47% against 27%, and 26% against 15%, improved on both sleep quality and morning alertness |
| Insomnia, aged 65 to 80, same tablet | 791 people aged 18 to 804 | Asleep 19.1 minutes sooner against 1.7 minutes on placebo in the older group |
| Night owls with a measured late clock | 116 people, 0.5 mg plus a fixed bedtime6 | Asleep 34 minutes earlier; 52.8% against 24.0% rated much improved |
| Delayed sleep phase, adults and children | 9 trials, 317 people7 | Clock moved 1.18 hours earlier, 23 minutes less to fall asleep |
| People on beta-blockers for blood pressure | 16 people, 2.5 mg for 3 weeks9 | 36 minutes more sleep, 14 minutes less to fall asleep |
The pooled 7 minutes most articles quote mixes people melatonin barely touches with people it helps a lot1. The large gains sit with three groups: older adults, people whose clock runs late, and people on a medicine that turns their own melatonin down. Pooled across adults with ordinary chronic insomnia, the gain was not significant, which is a fact about the problem, not a sign that the product is broken2.
How much to take, and at what hour for each job, is in the dose guide at pepvault.app/guides/melatonin-less-is-more.

PepVault for iPhone
Keep your protocol in PepVault
Set melatonin in your PepVault plan as an oral item with an evening time and switch on its reminder; if that night's dose is still unlogged, PepVault nudges you, so the hour stays the same night after night.
7 days free on the yearly plan for new subscribers.
Does low melatonin predict who responds?
Less than you would expect. In 372 insomnia patients aged 55 and over, the 30% whose overnight urine showed low melatonin responded a little more often to a 2 mg slow-release tablet, 58% against 47%5. That study had no placebo comparison for the response rate.
A larger placebo-controlled trial asked the question directly and came out the other way. In 791 adults aged 18 to 80, low melatonin output at any age did not predict a shorter time to fall asleep; age did. People aged 65 to 80 fell asleep 19.1 minutes sooner on the tablet against 1.7 minutes on placebo, whatever their own levels, and the gains held over 6 months with no sign of tolerance4. So a melatonin test adds little; your age and your clock say more.
Commonly reported: melatonin works from the first night for people who sleep late by nature, and does little for people who fall asleep fine but wake at 3 am and lie awake.
Are you a night owl or an insomniac?
Delayed sleep-wake phase disorder means the body clock runs late: you cannot fall asleep at a normal hour, but you sleep well when allowed to go to bed at 2 am and rise at 10. Insomnia means trouble sleeping even when bedtime matches your clock. Timed melatonin moves a late clock earlier, and the American Academy of Sleep Medicine backs strategically timed melatonin for the delayed clock8.
Feeling like a night owl is not proof of a late clock. In the 116-person trial every patient arrived with a clinical diagnosis, yet when the team measured the hour their own melatonin started rising, 62 of 186 (one in three) had a clock that was not late for the bedtime they wanted, and they were left out6. For the rest, 0.5 mg taken 1 hour before the bedtime they wanted, with that bedtime kept fixed, moved sleep 34 minutes earlier6.
Set melatonin in your PepVault plan as an oral item with an evening time and switch on its reminder; if that night's dose is still unlogged, PepVault nudges you, so the hour stays the same night after night. Set reminders in PepVault
What cancels melatonin in the evening?
Light, first. In 116 young adults, ordinary room light (under 200 lux) before bed delayed the start of their own melatonin in 99% of them and cut its nightly run by about 90 minutes11. Across 55 people, about 25 lux, the light of a dim living room, halved melatonin, and the most sensitive person's melatonin was halved at 6 lux, the least sensitive person's only at 350 lux12. Reading on a light-emitting tablet instead of a paper book delayed the clock, cut melatonin and left people less alert the next morning13.
Caffeine works on the clock too. A dose equal to a double espresso, taken 3 hours before bedtime, pushed the melatonin rhythm about 40 minutes later, close to half the shift caused by 3 hours of bright evening light14. Alcohol lowers the body's own melatonin in the first part of the night; that pairing has its own guide at pepvault.app/guides/melatonin-and-alcohol.
Which medicines and habits change melatonin levels?
Melatonin is cleared by the liver, mostly by an enzyme called CYP1A2. Slowing that enzyme raises the level a pill gives; speeding it lowers it. Circadin, Europe's prescription melatonin, lists the main ones in its label3. Beta-blockers work another way: they turn down the brain's own output10.
| Medicine or habit | What it does to melatonin | Source |
|---|---|---|
| Fluvoxamine (an antidepressant) | 17 times the total exposure and 12 times the peak; the label says the combination should be avoided | Circadin label3; 5 volunteers on 5 mg15 |
| Caffeine | Three 200 mg doses raised the peak of a 6 mg dose by 142% and total exposure by 120% | 12 volunteers16 |
| Smoking | The label: "may decrease melatonin levels"; exposure from a pill while smoking was about a third of the level after 7 days without | Circadin label3; 8 smokers17 |
| Oestrogens (the pill, hormone therapy) | Raise levels by slowing clearance; the label: "Caution should be exercised" | Circadin label3 |
| Quinolone antibiotics, cimetidine | Raise levels; caution with cimetidine, and quinolones "may give rise to increased melatonin exposure" | Circadin label3 |
| Carbamazepine, rifampicin | May lower levels | Circadin label3 |
| Propranolol, atenolol (beta-blockers) | One evening dose of their beta-blocking forms cut the body's own nightly melatonin by 80% and 86%; carvedilol did not | 15 volunteers10 |
A smoker may clear a pill before it does its job17. Someone on a beta-blocker may be short of their own night signal, and that is the group where adding melatonin showed one of the clearest gains, 36 extra minutes of sleep in a 3-week trial, with no rebound when it stopped910. Never stop or change a prescription medicine to make melatonin work: that decision is your prescriber's.
Can melatonin stop working over time?
The trials found no tolerance. In the 6-month trial the gains held or grew4, and in the beta-blocker trial people fell asleep faster even on the first night after stopping9.
There is one described exception, and it runs the opposite way to what people guess. In three Dutch patients with intellectual disability whose good response faded within weeks, melatonin was still high 4 hours after a dose, where it fell by 83% in patients who kept responding; their sleep recovered once the dose was cut well down18. The authors put it down to slow clearance by CYP1A2: the pill was staying too long, not too weak. That is a three-person case series, not a trial.
What should you check if melatonin is not working?
Go through these in order.
- Name your problem: sleeping well on a late schedule points to a late clock; lying awake whatever the hour points to insomnia, where melatonin does least26.
- Check the hour: in the night-owl trial it was taken 1 hour before the bedtime people wanted, with that bedtime fixed6. A slow-release tablet taken after food peaks at about 3 hours, against 45 minutes on an empty stomach3.
- Dim the last hours of the evening: low lamps and no bright screen, since even a dim room's light halved melatonin in the average person12.
- Move the last coffee earlier; a double espresso 3 hours before bed delayed the clock by about 40 minutes14.
- Check that the dose is not too high: a large dose can outlast the night (pepvault.app/guides/melatonin-less-is-more).
- List your medicines and whether you smoke, and show the list to a pharmacist: fluvoxamine, oestrogens, quinolones, carbamazepine, rifampicin and beta-blockers all change melatonin310.
- Keep the same wake time every day for a few weeks before you judge it; the night-owl trial ran 4 weeks6.
- If you have struggled to sleep for three months or more, ask about cognitive behavioural therapy for insomnia (CBT-I), the first treatment the American College of Physicians recommends19.
Today's check-in in PepVault rates your sleep and records the hours you slept, so the nights before and after each change sit side by side in one record. Log it in PepVault
When to get help Loud snoring, gasping in your sleep or heavy daytime sleepiness despite enough hours in bed are reasons to see a doctor, since sleep apnea (pepvault.app/conditions/sleep-apnea) is a different problem that melatonin does not treat.
What is CBT-I and why does it come first?
CBT-I is a structured course, with a therapist, a program or an app, that retrains the habits and thoughts that keep insomnia going. Its core parts are going to bed only when sleepy and getting up when you cannot sleep (stimulus control), and shrinking time in bed to the hours you actually sleep, then widening it (sleep restriction).
The American College of Physicians recommends CBT-I as the first treatment for every adult with chronic insomnia, a strong recommendation on moderate-quality evidence19. The American Academy of Sleep Medicine gives multicomponent CBT-I its strong grade too20, while its medicine guideline makes a weak suggestion against melatonin for chronic insomnia21. More on insomnia itself is at pepvault.app/conditions/insomnia, and every sleep compound in the library, ranked by evidence, is at pepvault.app/peptides/for/sleep.
Sources
- Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013. PubMed 23691095
- Choi K et al. Efficacy of melatonin for chronic insomnia: systematic reviews and meta-analyses. Sleep Med Rev. 2022. PubMed 36179487
- European Medicines Agency. Circadin 2 mg prolonged-release tablets: summary of product characteristics (EPAR product information). ema.europa.eu
- Wade AG et al. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Med. 2010. PubMed 20712869
- Leger D, Laudon M, Zisapel N. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med. 2004. PubMed 14715322
- Sletten TL et al. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: a double-blind, randomised clinical trial. PLoS Med. 2018. PubMed 29912983
- van Geijlswijk IM, Korzilius HP, Smits MG. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep. 2010. PubMed 21120122
- Auger RR et al. Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2015. PubMed 26414986
- Scheer FA et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012. PubMed 23024438
- Stoschitzky K et al. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol. 1999. PubMed 10335905
- Gooley JJ et al. Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab. 2011. PubMed 21193540
- Phillips AJK et al. High sensitivity and interindividual variability in the response of the human circadian system to evening light. Proc Natl Acad Sci U S A. 2019. PubMed 31138694
- Chang AM et al. Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. Proc Natl Acad Sci U S A. 2015. PubMed 25535358
- Burke TM et al. Effects of caffeine on the human circadian clock in vivo and in vitro. Sci Transl Med. 2015. PubMed 26378246
- Härtter S et al. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther. 2000. PubMed 10668847
- Härtter S et al. Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity. Br J Clin Pharmacol. 2003. PubMed 14616429
- Ursing C et al. Influence of cigarette smoking on melatonin levels in man. Eur J Clin Pharmacol. 2005. PubMed 15824912
- Braam W et al. Loss of response to melatonin treatment is associated with slow melatonin metabolism. J Intellect Disabil Res. 2010. PubMed 20576063
- Qaseem A et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016. PubMed 27136449
- Edinger JD et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021. PubMed 33164742
- Sateia MJ et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017. PubMed 27998379
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.